Pluristem Therapeutics (PSTI) Enters $30M Equity Investment Agreement with China's Innovative Medical

Pluristem Signs Term Sheet for $30 Million Equity Investment Agreement with a Leading Institutional Life Sciences Fund

Innovative Medical is a publicly listed Chinese Company active in the healthcare industry, and is an affiliate of ZSVC, one of the largest technology-focused VC firms in ChinaFunds to support late-stage pivotal trials for Pluristems cell therapiesShares will be sold at $1.77

HAIFA, Israel, Oct. 25, 2016 (GLOBE NEWSWIRE) --... More